BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33441290)

  • 1. [APOBEC3s: history of an antiviral and mutagenic protein family].
    Verriez C; Marquet R; Paillart JC; Stupfler B
    Virologie (Montrouge); 2020 Dec; 24(6):381-418. PubMed ID: 33441290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits.
    Cheng AZ; Moraes SN; Attarian C; Yockteng-Melgar J; Jarvis MC; Biolatti M; Galitska G; Dell'Oste V; Frappier L; Bierle CJ; Rice SA; Harris RS
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Insights into APOBEC3-Mediated Lentiviral Restriction.
    Delviks-Frankenberry KA; Desimmie BA; Pathak VK
    Viruses; 2020 May; 12(6):. PubMed ID: 32471198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOBEC3C Tandem Domain Proteins Create Super Restriction Factors against HIV-1.
    McDonnell MM; Crawford KHD; Dingens AS; Bloom JD; Emerman M
    mBio; 2020 Apr; 11(2):. PubMed ID: 32345636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
    Wang J; Shaban NM; Land AM; Brown WL; Harris RS
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer.
    Wang Y; Schmitt K; Guo K; Santiago ML; Stephens EB
    J Gen Virol; 2016 Jan; 97(1):1-17. PubMed ID: 26489798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
    Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity.
    Pautasso S; Galitska G; Dell'Oste V; Biolatti M; Cagliani R; Forni D; De Andrea M; Gariglio M; Sironi M; Landolfo S
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like family genes activation and regulation during tumorigenesis.
    Gao J; Choudhry H; Cao W
    Cancer Sci; 2018 Aug; 109(8):2375-2382. PubMed ID: 29856501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapy.
    Izumi T; Shirakawa K; Takaori-Kondo A
    Mini Rev Med Chem; 2008 Mar; 8(3):231-8. PubMed ID: 18336343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like Gene Expression, RNA Editing, and MicroRNAs Regulation.
    Cao W; Wu W
    Methods Mol Biol; 2018; 1699():75-81. PubMed ID: 29086369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism.
    Bogerd HP; Tallmadge RL; Oaks JL; Carpenter S; Cullen BR
    J Virol; 2008 Dec; 82(23):11889-901. PubMed ID: 18818324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human APOBEC3 Variations and Viral Infection.
    Sadeghpour S; Khodaee S; Rahnama M; Rahimi H; Ebrahimi D
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cytidine deaminases on innate immune responses against human viral infections.
    Vieira VC; Soares MA
    Biomed Res Int; 2013; 2013():683095. PubMed ID: 23865062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Naturally Occurring Domestic Cat APOBEC3 Variant Confers Resistance to Feline Immunodeficiency Virus Infection.
    Yoshikawa R; Izumi T; Yamada E; Nakano Y; Misawa N; Ren F; Carpenter MA; Ikeda T; Münk C; Harris RS; Miyazawa T; Koyanagi Y; Sato K
    J Virol; 2016 Jan; 90(1):474-85. PubMed ID: 26491161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing the Catalytic Deamination Activity of APOBEC3C Is Insufficient to Inhibit Vif-Deficient HIV-1.
    Jaguva Vasudevan AA; Hofmann H; Willbold D; Häussinger D; Koenig BW; Münk C
    J Mol Biol; 2017 Apr; 429(8):1171-1191. PubMed ID: 28315663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Footprint of the host restriction factors APOBEC3 on the genome of human viruses.
    Poulain F; Lejeune N; Willemart K; Gillet NA
    PLoS Pathog; 2020 Aug; 16(8):e1008718. PubMed ID: 32797103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
    Mangeat B; Turelli P; Caron G; Friedli M; Perrin L; Trono D
    Nature; 2003 Jul; 424(6944):99-103. PubMed ID: 12808466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The von Hippel-Lindau Cullin-RING E3 ubiquitin ligase regulates APOBEC3 cytidine deaminases.
    Scholtes GK; Sawyer AM; Vaca CC; Clerc I; Roh M; Song C; D'Aquila RT
    Transl Res; 2021 Nov; 237():1-15. PubMed ID: 34004371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiviral defense by APOBEC3 family proteins].
    Takaori A
    Uirusu; 2005 Dec; 55(2):267-72. PubMed ID: 16557012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.